Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 87INDUSTRY 37NETWORK 18NIH 13OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Lung Neoplasms 6Breast Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Urinary Bladder Neoplasms 2Nasopharyngeal Carcinoma 2Hodgkin Disease 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Neoplastic Cells, Circulating 1Locally Advanced Cervical Cancer 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Carcinoma, Transitional Cell 1

Interventions

Saline Solution 2Gemcitabine 2toripalimab 1apatorsen 1Standard of Care 1Mitomycin 1Magnetic Resonance Imaging 1Magnesium Sulfate 1Injections, Epidural 1Dexmedetomidine 1Cytological Techniques 1Cystoscopy 1Cisplatin 1Blood Transfusion 1BCG Vaccine 1BCG Connaught 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Urinary Bladder Neoplasms × Gemcitabine × Clear all
NCT06388720 2026-05-29

IMGeS

National Cancer Center, Korea

Phase 2 Recruiting
82 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT04553939 2026-01-02

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

Henan Cancer Hospital

Phase 2 Completed
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡